Similar articles

• Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.

  Sternberg CN, Parmar MK. Sternberg CN, et al. J Clin Oncol. 2001 Sep 15;19(18 Suppl):21S-26S. J Clin Oncol. 2001. PMID: 11560967 No abstract available.
• Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.

  Birtle AJ, Huddart RA. Birtle AJ, et al. BJU Int. 2006 Jun;97(6):1348; author reply 1348-50. doi: 10.1111/j.1464-410X.2006.06279_3.x. BJU Int. 2006. PMID: 16686740 No abstract available.
• Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.

  Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group. Segal R, et al. Can J Urol. 2002 Oct;9(5):1625-33. Can J Urol. 2002. PMID: 12431323
• Combined treatment approaches in regionally advanced bladder cancer.

  Walther PJ. Walther PJ. Urol Clin North Am. 1992 Nov;19(4):761-74. Urol Clin North Am. 1992. PMID: 1441030 Review.
• [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].

  Miyanaga N, Akaza H. Miyanaga N, et al. Gan To Kagaku Ryoho. 2007 Nov;34(11):1745-9. Gan To Kagaku Ryoho. 2007. PMID: 18030008 Review. Japanese.